March 1989
Volume 30, Issue 3
Free
Articles  |   March 1989
A comparison of CW Nd:YAG contact transscleral cyclophotocoagulation with cyclocryopexy.
Author Affiliations
  • H D Schubert
    Retina Service, Wills Eye Hospital, Philadelphia, PA 19107.
  • J L Federman
    Retina Service, Wills Eye Hospital, Philadelphia, PA 19107.
Investigative Ophthalmology & Visual Science March 1989, Vol.30, 536-542. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H D Schubert, J L Federman; A comparison of CW Nd:YAG contact transscleral cyclophotocoagulation with cyclocryopexy.. Invest. Ophthalmol. Vis. Sci. 1989;30(3):536-542.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

The cyclodestructive and inflammatory effects of CW Nd:YAG contact laser were compared to those of conventional cryopexy. CW Nd:YAG light transmitted by fiber optic cable and sapphire crystal was applied transsclerally to the ciliary body of pigmented and albino rabbits. Cyclocryopexy was given to a comparable second group. The intraocular pressure (IOP), flare, iritis, cells and conjunctival hyperemia were monitored clinically up to 3 weeks. The breakdown of the blood-aqueous barrier and time course of ocular inflammation was similar for both modalities and IOP was -12.2 +/- 4.2 mm Hg for laser cyclopexy and -15.1 +/- 5.4 mm Hg for cyclocryopexy at 3 weeks. Ciliary body lesions were noted in both groups. Overall, albino rabbits showed less histological damage and faster recovery of IOP. Contact cyclophotocoagulation and cyclocryopexy can be considered models of ocular injury. The similarities in ocular irritative response suggest a similar pathophysiologic mechanism underlying the pressure behavior in both thermal mode injuries.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×